ulcerative
Showing 76 - 100 of 2,804
Ulcerative Colitis Trial in Minneapolis (Fecal microbiota, Placebo)
Active, not recruiting
- Ulcerative Colitis
- Fecal microbiota
- Placebo
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 14, 2022
Disease Activity and Adverse Events of Rinvoq in Adult Moderate
Recruiting
- Ulcerative Colitis
-
Kurume-shi, Fukuoka, Japan
- +4 more
Mar 17, 2023
Johns Hopkins Crohn's Disease and Ulcerative Colitis Study
Active, not recruiting
- Inflammatory Bowel Disease
-
Baltimore, MarylandJohns Hopkins University
Dec 6, 2022
Finland Treated With Tofacitinib for Treatment of Ulcerative
Completed
- Ulcerative Colitis
-
Helsinki, FinlandPfizer
Dec 15, 2022
Ulcerative Colitis, IBD Trial in Oslo (IDOFORM®Travel)
Recruiting
- Ulcerative Colitis
- Inflammatory Bowel Diseases
- IDOFORM®Travel
-
Oslo, NorwayOslo University Hospital
Sep 20, 2022
IBD Trial (Pentoxifylline 400 MG)
Not yet recruiting
- Inflammatory Bowel Diseases
- Pentoxifylline 400 MG
- (no location specified)
Oct 28, 2022
Ulcerative Colitis Trial in Dongcheng (Treatment group: Rectal instillation of QHQYP, Control group: Mesalazine enema treatment)
Not yet recruiting
- Ulcerative Colitis
- Treatment group: Rectal instillation of QHQYP
- Control group: Mesalazine enema treatment
-
Dongcheng, Beijing, ChinaBeijing Hospital of Traditional Chinese Medicine, Capital Medica
Mar 21, 2023
IBD Trial (Atorvastatin 80mg)
Not yet recruiting
- Inflammatory Bowel Diseases
- Atorvastatin 80mg
- (no location specified)
Oct 14, 2022
IBD Trial in Tanta (Mesalamine, Fenofibrate 160mg)
Recruiting
- Inflammatory Bowel Diseases
- Mesalamine
- Fenofibrate 160mg
-
Tanta, EgyptTanta Unuversity
Mar 6, 2023
Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative Trial (PL8177 Placebo, PL8177)
Not yet recruiting
- Ulcerative Colitis
- +3 more
- PL8177 Placebo
- PL8177
- (no location specified)
Jul 18, 2022
Russian Extremely Severe Ulcerative Colitis Study
Completed
- Ulcerative Colitis
- Inflammatory Bowel Diseases
-
Moscow, Russian FederationState Scientific Centre of Coloproctology, Russian Federation
Aug 24, 2022
Ulcerative Colitis, Ulcerative Colitis Chronic Mild Trial in Ann Arbor (1 Serving of broccoli sprouts, 3 Servings of broccoli
Not yet recruiting
- Ulcerative Colitis
- Ulcerative Colitis Chronic Mild
- 1 Serving of broccoli sprouts
- 3 Servings of broccoli sprouts
-
Ann Arbor, MichiganUniversity of Michigan
Aug 17, 2022
IBD Trial in Mansoura (Metformin)
Recruiting
- Inflammatory Bowel Diseases
-
Mansoura, EgyptFaculty of Medicine, Mansoura University
Nov 2, 2022
Ulcerative Colitis (UC) Trial in Stockholm (TLA Gut™)
Recruiting
- Ulcerative Colitis (UC)
- TLA Gut™
-
Stockholm, SwedenErsta Sjukhus, Medicinkliniken
Nov 7, 2022
Ulcerative Colitis Trial (MitoQ, Placebo)
Not yet recruiting
- Ulcerative Colitis
- MitoQ
- Placebo
- (no location specified)
Sep 13, 2022
IBD Trial (Atorvastatin 80mg, Mesalamine)
Not yet recruiting
- Inflammatory Bowel Diseases
- Atorvastatin 80mg
- Mesalamine
- (no location specified)
Oct 14, 2022
IBD Trial in Tanta (Mesalamine, Fenofibrate)
Recruiting
- Inflammatory Bowel Diseases
-
Tanta, Shebeen El-Kom, EgyptFaculty of Medicine, Menoufia University
Mar 11, 2023
Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe, Rectal Ulcer Trial in Xi'an (other, drug, biological)
Not yet recruiting
- Ulcerative Colitis Chronic Moderate
- +2 more
- Autologous Platelet-rich Plasma (PRP) and Thrombin Coagulum Treatment
- +3 more
-
Xi'an, Shaanxi, ChinaXijing Digestive Disease
Jun 12, 2023
Ulcerative Colitis Trial in Wageningen (Prebiotics, Placebo)
Not yet recruiting
- Ulcerative Colitis
- Prebiotics
- Placebo
-
Wageningen, Gelderland, NetherlandsWageningen University
Oct 11, 2022
Ulcerative Colitis (UC) Trial in Guangzhou (Placebo, IBI112)
Recruiting
- Ulcerative Colitis (UC)
- Placebo
- IBI112
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital of Sun Yat-sen University
Sep 20, 2022
IBD Trial in Mansoura (Pentoxifylline 400 MG)
Recruiting
- Inflammatory Bowel Diseases
- Pentoxifylline 400 MG
-
Mansoura, EgyptFaculty of Medicine, Mansoura University
Oct 28, 2022